Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia

Completed · Phase 2 · Has a placebo group

Conditions studied: Schizophrenia

In brief

This study will evaluate the effectiveness of galantamine and CDP-choline in improving symptoms associated with schizophrenia.

Key facts

Study ID

NCT00509067

Run by

Georgetown University

People needed

43

Starts

2007-11-01

Expected to finish

2011-03-01

Last updated by the study team

2018-04-11

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets DSM-IV criteria for schizophrenia or schizoaffective disorder
• Eligible for care within the Veterans Affairs Medical system
• Taking risperidone, olanzapine, quetiapine, ziprasidone, and/or aripiprazole (oral or injection)

You may not qualify if…

• Significant liver, kidney, lung, endocrine, active peptic ulcer, or cardiovascular disease
• Seizure disorder and/or head injury
• Substance use or abuse within 3 months of study entry
• Pregnant

Where it is running

• Washington Veterans Affairs Medical Center — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.